Probiotics and prebiotics are CAM interventions frequently employed by the American public to promote intestinal health and wellness. The presence of beneficial bacteria such as lactobacilli and bifidobacteria, whether delivered exogenously as probiotics or enriched via prebiotics, has been linked to positive health effects including reduction of gut inflammation, diarrhea and allergic reactions. At present however, our understanding of the mechanism of action underlying these biological effects is significantly lacking. Milk oligosaccharides are naturally-evolved prebiotic substrates that facilitate bifidobacterial enrichment and interaction within the infant host. Work from the UC Davis Milk Bioactives Program has shown that human milk oligosaccharides are utilized by select infant-borne bifidobacterial strains that demonstrated unique preferences in oligosaccharide consumption. In addition, genomic analysis of Bifidobacterium infantis and Bifidobacterium bifidum, two strains that grow well on milk oligosaccharides, has revealed unique gene clusters that are specifically induced during growth on these glycans. Further analysis has revealed that growth on milk glycans results in enhanced bifidobacterial interaction with the host epithelium. We hypothesize that the evolutionarily-driven relationship between milk oligosaccharides and cognate infant-borne bifidobacteria provides a model for enhanced probiotic persistence within, and interaction with, the human host. To address this hypothesis we will gain mechanistic insight into the specific catabolism of these unique milk glycans by bifidobacteria and comprehensively map their influence on bifidobacteria-host interaction via the following Specific Aims: 1. To comprehensively characterize human and bovine milk oligosaccharides and develop methods for their large scale fractionation and production for functional studies. 2. To completely characterize the bifidobacterial transporters and glycosyl hydrolases necessary to deconstruct these complex milk oligosaccharides. 3. To examine the influence of milk oligosaccharides on the interaction between bifidobacteria and the host. Successful completion of these Specific Aims will reveal specific mechanisms by which human milk oligosaccharides facilitate a protective enrichment of bifidobacteria in the gastrointestinal tract of breast fed infants. In addition, we will translate these findings to structurally and functionally equivalent bovine milk oligosaccharides, a commercially accessible substrate that can be easily delivered into CAM foods and therapies aimed at gut health. The significance of this application is a greater mechanistic understanding of the beneficial effects of synbiotic (milk oligosaccahrides plus cognate bifidobacteria) applications thereby providing both strategies and diagnostic measures to better address a variety of disorders marked by intestinal dysbiosis.

Public Health Relevance

Probiotics and prebiotics (complex carbohydrates preferred by probiotics) are frequently used by the American public to promote intestinal health and wellness. These probiotics have been linked to positive health effects including reduction of gut inflammation, diarrhea and allergic reactions. Using prebiotics that naturally evolved in human and bovine milk, the proposed research will study the underlying mechanisms whereby milk prebiotics (milk oligosaccharides) enrich probiotic bacterial growth and interaction with cells in the mammalian gut.

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Research Project (R01)
Project #
5R01AT007079-03
Application #
8651901
Study Section
Special Emphasis Panel (ZAT1)
Program Officer
Duffy, Linda C
Project Start
2012-04-01
Project End
2017-03-31
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
3
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of California Davis
Department
Other Basic Sciences
Type
Earth Sciences/Resources
DUNS #
City
Davis
State
CA
Country
United States
Zip Code
95618
Lewis, Zachery T; Shani, Guy; Masarweh, Chad F et al. (2016) Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr Res 79:445-52
Yang, Nan; Goonatilleke, Elisha; Park, Dayoung et al. (2016) Quantitation of Site-Specific Glycosylation in Manufactured Recombinant Monoclonal Antibody Drugs. Anal Chem 88:7091-100
Dallas, David C; Citerne, Florine; Tian, Tian et al. (2016) Peptidomic analysis reveals proteolytic activity of kefir microorganisms on bovine milk proteins. Food Chem 197:273-84
Hutkins, Robert W; Krumbeck, Janina A; Bindels, Laure B et al. (2016) Prebiotics: why definitions matter. Curr Opin Biotechnol 37:1-7
Charbonneau, Mark R; Blanton, Laura V; DiGiulio, Daniel B et al. (2016) A microbial perspective of human developmental biology. Nature 535:48-55
Martín-Ortiz, A; Salcedo, J; Barile, D et al. (2016) Characterization of goat colostrum oligosaccharides by nano-liquid chromatography on chip quadrupole time-of-flight mass spectrometry and hydrophilic interaction liquid chromatography-quadrupole mass spectrometry. J Chromatogr A 1428:143-53
Garrido, Daniel; Ruiz-Moyano, Santiago; Kirmiz, Nina et al. (2016) A novel gene cluster allows preferential utilization of fucosylated milk oligosaccharides in Bifidobacterium longum subsp. longum SC596. Sci Rep 6:35045
Karav, Sercan; Le Parc, Annabelle; Leite Nobrega de Moura Bell, Juliana Maria et al. (2016) Oligosaccharides Released from Milk Glycoproteins Are Selective Growth Substrates for Infant-Associated Bifidobacteria. Appl Environ Microbiol 82:3622-30
Davis, Jasmine C C; Totten, Sarah M; Huang, Julie O et al. (2016) Identification of Oligosaccharides in Feces of Breast-fed Infants and Their Correlation with the Gut Microbial Community. Mol Cell Proteomics 15:2987-3002
Subramanian, Sathish; Blanton, Laura V; Frese, Steven A et al. (2015) Cultivating healthy growth and nutrition through the gut microbiota. Cell 161:36-48

Showing the most recent 10 out of 52 publications